Effects of chondroitin sulfate on brain response to painful stimulation in knee osteoarthritis patients. A randomized, double-blind, placebo-controlled functional magnetic resonance imaging study
Med Clin (Barc). 2017 Jun 21;148(12):539-547.
doi: 10.1016/j.medcli.2016.12.036.
Epub 2017 Feb 22.
[Article in
English,
Spanish]
Authors
Jordi Monfort
1
, Jesús Pujol
2
, Oren Contreras-Rodríguez
3
, Jone Llorente-Onaindia
1
, Marina López-Solà
4
, Laura Blanco-Hinojo
3
, Josep Vergés
5
, Marta Herrero
5
, Laura Sánchez
5
, Hector Ortiz
3
, Francisco Montañés
6
, Joan Deus
7
, Pere Benito
1
Affiliations
- 1 Departamento de Reumatología, Hospital del Mar, Barcelona, España.
- 2 Unidad de Investigación en RM, Hospital del Mar, Cibersam G21, Barcelona, España. Electronic address: [email protected].
- 3 Unidad de Investigación en RM, Hospital del Mar, Cibersam G21, Barcelona, España.
- 4 Unidad de Investigación en RM, Hospital del Mar, Cibersam G21, Barcelona, España; Department of Psychology and Neuroscience. University of Colorado Boulder, Colorado, Estados Unidos.
- 5 Área de Investigación y Desarrollo Clínico, División de Farma-Ciencia, Bioibérica, Barcelona, España.
- 6 Centro de Atención Sanitaria Primaria Vila Olímpica (PAMEM), Barcelona, España.
- 7 Unidad de Investigación en RM, Hospital del Mar, Cibersam G21, Barcelona, España; Departamento de Psicología Clínica y Sanitaria, Universidad Autónoma de Barcelona, Barcelona, España.
Abstract
Introduction:
Knee osteoarthritis is causing pain and functional disability. One of the inherent problems with efficacy assessment of pain medication was the lack of objective pain measurements, but functional magnetic resonance imaging (fMRI) has emerged as a useful means to objectify brain response to painful stimulation. We have investigated the effect of chondroitin sulfate (CS) on brain response to knee painful stimulation in patients with knee osteoarthritis using fMRI.
Methods:
Twenty-two patients received CS (800mg/day) and 27 patients placebo, and were assessed at baseline and after 4 months of treatment. Two fMRI tests were conducted in each session by applying painful pressure on the knee interline and on the patella surface. The outcome measurement was attenuation of the response evoked by knee painful stimulation in the brain.
Results:
fMRI of patella pain showed significantly greater activation reduction under CS compared with placebo in the region of the mesencephalic periaquecductal gray. The CS group, additionally showed pre/post-treatment activation reduction in the cortical representation of the leg. No effects of CS were detected using the interline pressure test.
Conclusions:
fMRI was sensitive to objectify CS effects on brain response to painful pressure on patellofemoral cartilage, which is consistent with the known CS action on chondrocyte regeneration. The current work yields further support to the utility of fMRI to objectify treatment effects on osteoarthritis pain.
Keywords:
Artrosis de rodilla; Chondroitin sulfate; Condroitín sulfato; Dolor; Functional magnetic resonance image; Knee osteoarthritis; Pain; Resonancia magnética funcional.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Analgesics / pharmacology*
-
Analgesics / therapeutic use
-
Chondroitin Sulfates / pharmacology*
-
Chondroitin Sulfates / therapeutic use
-
Double-Blind Method
-
Drug Administration Schedule
-
Female
-
Follow-Up Studies
-
Humans
-
Magnetic Resonance Imaging*
-
Male
-
Middle Aged
-
Neuroimaging*
-
Osteoarthritis, Knee / drug therapy*
-
Pain Measurement / methods*
-
Pain Perception / drug effects*
-
Periaqueductal Gray / diagnostic imaging
-
Periaqueductal Gray / drug effects
-
Treatment Outcome
Substances
-
Analgesics
-
Chondroitin Sulfates